VIR
Vir Biotechnology IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$1.66B
P/E Ratio
—
EPS
$-3.16
Beta
1.66
52W High
$11.66
52W Low
$4.16
50-Day MA
$9.38
200-Day MA
$6.70
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
4.27
PEG Ratio
—
About Vir Biotechnology Inc
Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. The company is headquartered in San Francisco, California.
Fundamentals
| Revenue (TTM) | $68.56M |
| Gross Profit (TTM) | $-375.95M |
| EBITDA | $-456.34M |
| Operating Margin | -74.90% |
| Return on Equity | -45.70% |
| Return on Assets | -24.40% |
| Revenue/Share (TTM) | $0.49 |
| Book Value | $5.49 |
| Price-to-Book | 2.24 |
| Price-to-Sales (TTM) | 24.18 |
| EV/Revenue | 20.24 |
| EV/EBITDA | 0.90 |
| Quarterly Earnings Growth (YoY) | 58.50% |
| Quarterly Revenue Growth (YoY) | 417.80% |
| Shares Outstanding | $161.23M |
| Float | $103.15M |
| % Insiders | 6.84% |
| % Institutions | 71.05% |
Historical Volatility
HV 10-Day
46.80%
HV 20-Day
50.64%
HV 30-Day
51.98%
HV 60-Day
75.00%
HV Rank
3.2%
Volatility is currently contracting
Analyst Ratings
Consensus ($20.78 target)
3
Strong Buy7
BuyData last updated: 4/29/2026